SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (2084)3/28/2017 10:48:31 PM
From: Felix B  Read Replies (1) | Respond to of 3559
 
They already have Express Scripts on board:

forbes.com



To: Miljenko Zuanic who wrote (2084)3/29/2017 3:43:04 PM
From: DewDiligence_on_SI  Read Replies (1) | Respond to of 3559
 
...they may not have smooth sailing, initially.
According to yesterday's CC, there will be no undue red tape—such as long forms and lab reports to be completed by physicians—to impede approval of reimbursement.
Based on recent reading about IL4/13 and asthma...I am expecting breakthrough for that indication as well.
Why are you mentioning that in this dialog?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News